COMMUNIQUÉS West-GlobeNewswire

CROSSJECT : Accord commercial avec DESITIN Pharma sur ZENEO® Midazolam en Allemagne
18/06/2019
Communiqué de presse Accord commercial avec DESITIN Pharma sur ZENEO® Midazolam en Allemagne DESITIN, acteur majeur dans le domaine de l’épilepsie en Allemagne Licence exclusive, accord de distribution et de promotion 2 [...]
Teligent, Inc. to Present at the Raymond James Life Sciences and MedTech Conference on June 19th 2019
18/06/2019
BUENA, N.J., June 18, 2019 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey based specialty generic pharmaceutical company, will be presenting at the Raymond James Life Sciences and MedTech Conference [...]
North Bud Farms Signs Binding Letter of Intent to Acquire California Licensed Extraction Company Tanforan Ventures
18/06/2019
TORONTO, June 18, 2019 (GLOBE NEWSWIRE) -- North Bud Farms Inc. (CSE: NBUD) (OTCQB: NOBDF) ("NORTHBUD" or the "Company") is pleased to announce that effective June 15, 2019 it has entered into a binding letter of intent [...]
Pathway Health Announces Distribution Agreement with Briggs Healthcare
18/06/2019
LAKE ELMO, Minn., June 18, 2019 (GLOBE NEWSWIRE) -- Pathway Health , a leading post-acute consulting services, strategic technology implementation, and education services firm, has signed a distribution agreement with [...]
Harrow Health, Inc to Locate Headquarters in Nashville, Tennessee
18/06/2019
NASHVILLE, Tenn., June 18, 2019 (GLOBE NEWSWIRE) -- Tennessee Governor, Bill Lee, Department of Economic and Community Development Commissioner Bob Rolfe and Harrow Health, Inc (NASDAQ: HROW) announced today that the [...]
Rinovum Women’s Health Debuts All-New Over-the-Counter Product Designed to Treat Stress Urinary Incontinence and Boost Women’s Confidence
18/06/2019
Makers of successful Stork® products for at-home conception take on light bladder leaks, a condition impacting more than 15 million women in the United States PITTSBURGH, June 18, 2019 (GLOBE NEWSWIRE) -- Rinovum Women’ [...]
Progenics Pharmaceuticals Announces Agreement with FUJIFILM Toyama Chemical Co. for Automated Bone Scan Index (aBSI) Product in Japan
18/06/2019
aBSI Leverages Artificial Intelligence to Automatically and Reliably Analyze Bone Scan Images from Prostate Cancer Patients NEW YORK, June 18, 2019 (GLOBE NEWSWIRE) -- Progenics Pharmaceuticals, Inc. (Nasdaq:PGNX), an [...]
PROJECT HOPE ANNOUNCES TRANSITIONS IN EXECUTIVE LEADERSHIP
18/06/2019
Global health and humanitarian relief organization positions for continued growth and innovation Millwood, Virginia, June 18, 2019 (GLOBE NEWSWIRE) -- The board of directors of Project HOPE has named Rabih Torbay [...]
ContraVir Pharmaceuticals, Inc. Announces Pricing of $15.6 Million Public Offering
18/06/2019
EDISON, N.J., June 18, 2019 (GLOBE NEWSWIRE) -- ContraVir Pharmaceuticals, Inc. (“ContraVir,” the “Company,” “we,” “our” or “us”) (NASDAQ:CTRV), a biopharmaceutical company focused on the development of therapeutic [...]
Wildflower Featured in CannabisNewsWire Publication Highlighting Legal Cannabis as a Global Profit Phenomenon
18/06/2019
NEW YORK, June 18, 2019 (GLOBE NEWSWIRE) -- via CannabisNewsWire -- Wildflower Brands Inc. (OTCQB:WLDFF) (CSE:SUN) today announces its placement in an editorial published by CannabisNewsWire ("CNW"), a multifaceted [...]
Anchiano Therapeutics Delists Ordinary Shares from the Tel Aviv Stock Exchange
18/06/2019
CAMBRIDGE, Mass., June 18, 2019 (GLOBE NEWSWIRE) -- Anchiano Therapeutics Ltd. (Nasdaq: ANCN) (“Anchiano”), a pivotal-stage biopharmaceutical company focused on the discovery and development of novel therapies to treat [...]
Menlo Therapeutics Announces Addition of Ronald A. Krasnow as General Counsel and Chief Compliance Officer
18/06/2019
REDWOOD CITY, Calif., June 18, 2019 (GLOBE NEWSWIRE) -- Menlo Therapeutics Inc. (NASDAQ: MNLO), a late-stage biopharmaceutical company focused on the development of serlopitant for the treatment of pruritus (itch), [...]
Cassava Sciences to Present at Maxim Group’s Conference on Alzheimer’s Disease
18/06/2019
AUSTIN, Texas, June 18, 2019 (GLOBE NEWSWIRE) -- Cassava Sciences, Inc. (Nasdaq: SAVA), a clinical-stage biotechnology company, announced today that Remi Barbier, its President and CEO, will present at Maxim Group’s [...]
Abeona Therapeutics Receives FDA Fast Track Designation for ABO-202 AAV9 Gene Therapy in CLN1 Disease
18/06/2019
NEW YORK and CLEVELAND, June 18, 2019 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO), a fully-integrated leader in gene and cell therapy, today announced that the U.S. Food and Drug Administration (FDA) has [...]
Aptinyx to Present at the 2019 BMO Prescription for Success Healthcare Conference
18/06/2019
EVANSTON, Ill., June 18, 2019 (GLOBE NEWSWIRE) -- Aptinyx Inc. (Nasdaq: APTX), a clinical-stage biopharmaceutical company developing transformative therapies for the treatment of brain and nervous system disorders, [...]
Nu-Med Plus, Inc. Approaches Milestone FDA Application for New Nitric Oxide Medical Device Approval
18/06/2019
Innovative Nitric Oxide Delivery Device Company Announces Addition of FDA Advisor SALT LAKE CITY, June 18, 2019 (GLOBE NEWSWIRE) -- Nu-Med Plus, Inc . (OTCQB: NUMD), a medical device leader developing new nitric oxide [...]
Nevakar Enters $50 Million Product Financing Agreement with NovaQuest Capital for Continued Development of Injectable Products
18/06/2019
BRIDGEWATER, N.J. and RALEIGH, N.C., June 18, 2019 (GLOBE NEWSWIRE) -- Nevakar Inc. (“Nevakar” or the “Company”), a specialty pharmaceutical company developing multiple assets in the ophthalmic and injectable areas, [...]
Eidos Therapeutics to Present at the 2019 BMO Prescriptions for Success Healthcare Conference
18/06/2019
SAN FRANCISCO, June 18, 2019 (GLOBE NEWSWIRE) -- Eidos Therapeutics, Inc. (Eidos) (Nasdaq:EIDX) today announced that management will participate in a fireside chat at the 2019 BMO Prescriptions for Success Healthcare [...]
Jounce Therapeutics Initiates Phase 2 EMERGE Study of Vopratelimab in Combination with Ipilimumab in Patients with Non-Small Cell Lung Cancer or Urothelial Cancer
18/06/2019
- Commenced patient enrollment in Phase 2 clinical trial of vopratelimab in combination with ipilimumab - - Preliminary efficacy and relationship to biomarker data expected in 2020 - CAMBRIDGE, Mass., June 18, 2019 ( [...]

Pages